Results 131 to 140 of about 11,739 (212)

[Construction and evaluation of an artificial intelligence-based risk prediction model for death in patients with nasopharyngeal cancer]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2023
Zhang H, Lu J, Jiang C, Fang M.
europepmc   +1 more source

[The analysis of invention patents in the field of artificial intelligent medical devices]. [PDF]

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
Zhang T, Chen J, Lu Y, Xu D, Yan S, Ouyang Z.   +5 more
europepmc   +1 more source

深度学习在甲状腺疾病诊疗中的应用与展望

Zhongguo shiyan zhenduanxue
1956年，JOHN MCCARTHY将人工智能（artificial intelligence, AI）描述为“制造智能机器和科学的工程”,这标志着人工智能的诞生[1]。但直到21世纪初AI才在医学领域崭露头角[2]。甲状腺疾病的发病率逐年上升，疾病的年轻化趋势、术中喉返神经及甲状旁腺损伤风险和术后长期服药使甲状腺疾病的诊疗过程受到越来越多人的关注。由于检查手段的提高和医生水平的不同导致的过度诊疗及漏诊和误诊是现今存在的问题。
李昱川, 张翼, 张纯海
doaj  

[Artificial intelligence applications in Ménière's disease]. [PDF]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
Zhou Z, Zhang Y, Mao Q, Wang Q.
europepmc   +1 more source

[Application and development of voice analysis and endoscopic technology combined with artificial intelligence in the diagnosis and treatment of throat disease]. [PDF]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2022
Song Q, Li X.
europepmc   +1 more source

[Analysis of the global registration status of clinical trials for artificial intelligence medical device]. [PDF]

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
Lu Y, Chen J, Zhang T, Yan S, Xu D, Ouyang Z.   +5 more
europepmc   +1 more source

[Analysis of the global competitive landscape in artificial intelligence medical device research]. [PDF]

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
Chen J, Pan L, Long J, Yang N, Liu F, Lu Y, Ouyang Z.   +6 more
europepmc   +1 more source

世界主要国家科技重点领域遴选识别分析 [PDF]

, 2018
刘细文, 吴鸣, 杨小薇, 王辉, 靳茜   +4 more
core  

[Application of Artificial Intelligence in Sperm Quality Analysis and Sperm Screening]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Pang J, Hou W, Nong Y, Bian A, Xu W.
europepmc   +1 more source

[Advancements in artificial intelligence for the precise diagnosis and treatment of hematological malignancies]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Yang HX, Xiong J, Zhao WL.
europepmc   +1 more source